<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://wiki1.b.seossd.bitactive.com/index.php?action=history&amp;feed=atom&amp;title=Stop_Wasting_Time_And_Start_Xarelto_Lawsuit</id>
		<title>Stop Wasting Time And Start Xarelto Lawsuit - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://wiki1.b.seossd.bitactive.com/index.php?action=history&amp;feed=atom&amp;title=Stop_Wasting_Time_And_Start_Xarelto_Lawsuit"/>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Stop_Wasting_Time_And_Start_Xarelto_Lawsuit&amp;action=history"/>
		<updated>2026-06-17T23:59:13Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.29.0</generator>

	<entry>
		<id>http://wiki1.b.seossd.bitactive.com/index.php?title=Stop_Wasting_Time_And_Start_Xarelto_Lawsuit&amp;diff=229507&amp;oldid=prev</id>
		<title>149.56.19.200 at 19:12, 25 April 2018</title>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Stop_Wasting_Time_And_Start_Xarelto_Lawsuit&amp;diff=229507&amp;oldid=prev"/>
				<updated>2018-04-25T19:12:38Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&#039;diff-marker&#039; /&gt;
				&lt;col class=&#039;diff-content&#039; /&gt;
				&lt;col class=&#039;diff-marker&#039; /&gt;
				&lt;col class=&#039;diff-content&#039; /&gt;
				&lt;tr style=&#039;vertical-align: top;&#039; lang=&#039;en&#039;&gt;
				&lt;td colspan=&#039;2&#039; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&#039;2&#039; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Revision as of 19:12, 25 April 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;sufferers &lt;/del&gt;who took the blood thinner Xarelto (rivaroxaban) and suffered &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;critical &lt;/del&gt;bleeding events. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;[http://Www.Theepochtimes.com/n3/search/?q=Pharmaceutical &lt;/del&gt;Pharmaceutical&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;] firms&lt;/del&gt;, such as the makers of Xarelto, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;have &lt;/del&gt;a duty to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;make sure &lt;/del&gt;that their drugs are reasonably &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;secure &lt;/del&gt;for use - and failure to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;accomplish &lt;/del&gt;so &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;may possibly &lt;/del&gt;be grounds for compensation. Our lawyers are &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;working &lt;/del&gt;challenging to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;obtain &lt;/del&gt;those hurt by the drug the compensation they &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;may be &lt;/del&gt;entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Although &lt;/del&gt;bleeding &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;can be &lt;/del&gt;a &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;frequent &lt;/del&gt;complication connected with anticoagulants, it has been alleged that Xarelto is &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;a lot &lt;/del&gt;more &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;unsafe &lt;/del&gt;than classic blood thinners &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;due to the fact &lt;/del&gt;no &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;antidote exists to reverse its blood-thinning &lt;/del&gt;[http://&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;xareltoattorneys&lt;/del&gt;.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;bitbucket&lt;/del&gt;.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;org&lt;/del&gt;/&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;categories&lt;/del&gt;/&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Washington/Xarelto&lt;/del&gt;-&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Class-Action-Milton-WA-98354.html side &lt;/del&gt;effects &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;to xarelto]&lt;/del&gt;. This indicates that, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;inside &lt;/del&gt;the event of an emergency, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;sufferers may possibly &lt;/del&gt;be at &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;threat &lt;/del&gt;for irreversible bleeding &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;issues&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;like &lt;/del&gt;life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;In case &lt;/del&gt;you or &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;possibly &lt;/del&gt;a loved &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;1 &lt;/del&gt;suffered a &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;serious &lt;/del&gt;bleeding &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;event right &lt;/del&gt;after taking Xarelto, you may have legal recourse. For a lot more &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;data&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;get in touch with &lt;/del&gt;us &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;today &lt;/del&gt;to possess your case reviewed, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;cost-&lt;/del&gt;free of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;in search of &lt;/del&gt;compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Moreover&lt;/del&gt;, they &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;are &lt;/del&gt;seeking punitive damages, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;which &lt;/del&gt;are typically awarded to punish the defendant and deter other &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;firms &lt;/del&gt;from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits Getting Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;standard &lt;/del&gt;anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Because &lt;/del&gt;of this, the lawsuits claim, doctors have no effective &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;means &lt;/del&gt;of stopping Xarelto users from bleeding inside the &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;event &lt;/del&gt;of an emergency. Plaintiffs &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;in &lt;/del&gt;the lawsuits allege &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;severe &lt;/del&gt;and fatal injuries, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;which includes &lt;/del&gt;cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;secure &lt;/del&gt;anticoagulant option.&amp;lt;br&amp;gt;Doctors and &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;healthcare &lt;/del&gt;staff were not properly made aware of methods to stabilize and treat a Xarelto user &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;inside &lt;/del&gt;the occasion of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.&amp;lt;br&amp;gt;Xarelto is linked to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;serious &lt;/del&gt;bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;hazardous &lt;/del&gt;clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for much more &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;information &lt;/del&gt;on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;patients [https://tortlawyers.s3.amazonaws.com/categories/Xarelto-Lawsuit-Attorneys-in-Vermont/index.html &lt;/ins&gt;who &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;produces xarelto] &lt;/ins&gt;took the blood thinner Xarelto (rivaroxaban) and suffered &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;severe &lt;/ins&gt;bleeding events. Pharmaceutical &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;organizations&lt;/ins&gt;, such as the makers of Xarelto, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;possess &lt;/ins&gt;a duty to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;ensure &lt;/ins&gt;that their drugs are reasonably &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;safe &lt;/ins&gt;for use - and failure to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;complete &lt;/ins&gt;so &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;could &lt;/ins&gt;be grounds for compensation. Our lawyers are &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;operating &lt;/ins&gt;challenging to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;get &lt;/ins&gt;those hurt by the drug the compensation they &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;are &lt;/ins&gt;entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Whilst &lt;/ins&gt;bleeding &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;is really &lt;/ins&gt;a &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;typical &lt;/ins&gt;complication connected with anticoagulants, it has been alleged that Xarelto is more &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;hazardous &lt;/ins&gt;than classic blood thinners &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;simply because &lt;/ins&gt;no [http://&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;www&lt;/ins&gt;.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;sharkbayte&lt;/ins&gt;.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;com&lt;/ins&gt;/&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;keyword&lt;/ins&gt;/&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;antidote antidote] exists to reverse its blood&lt;/ins&gt;-&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;thinning &lt;/ins&gt;effects. This indicates that, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;in &lt;/ins&gt;the event of an emergency, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;individuals might &lt;/ins&gt;be at &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;danger &lt;/ins&gt;for irreversible bleeding &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;problems&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;such as &lt;/ins&gt;life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Should &lt;/ins&gt;you or a loved &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;one &lt;/ins&gt;suffered a &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;significant &lt;/ins&gt;bleeding &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;occasion &lt;/ins&gt;after taking Xarelto, you may have legal recourse. For a lot more &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;details&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;speak to &lt;/ins&gt;us &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;right now &lt;/ins&gt;to possess your case reviewed, free of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;seeking &lt;/ins&gt;compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;In addition&lt;/ins&gt;, they&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;&amp;#039;re &lt;/ins&gt;seeking punitive damages, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;that &lt;/ins&gt;are typically awarded to punish the defendant and deter other &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;organizations &lt;/ins&gt;from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits Getting Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;traditional &lt;/ins&gt;anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Due to the fact &lt;/ins&gt;of this, the lawsuits claim, doctors have no effective &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;indicates &lt;/ins&gt;of stopping Xarelto users from bleeding inside the &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;occasion &lt;/ins&gt;of an emergency. Plaintiffs &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;inside &lt;/ins&gt;the lawsuits allege &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;critical &lt;/ins&gt;and fatal injuries, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;such as &lt;/ins&gt;cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;protected &lt;/ins&gt;anticoagulant option.&amp;lt;br&amp;gt;Doctors and &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;health-related &lt;/ins&gt;staff were not properly made aware of methods to stabilize and treat a Xarelto user &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;in &lt;/ins&gt;the occasion of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.&amp;lt;br&amp;gt;Xarelto is linked to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;critical &lt;/ins&gt;bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;dangerous &lt;/ins&gt;clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for much more &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;data &lt;/ins&gt;on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>149.56.19.200</name></author>	</entry>

	<entry>
		<id>http://wiki1.b.seossd.bitactive.com/index.php?title=Stop_Wasting_Time_And_Start_Xarelto_Lawsuit&amp;diff=175268&amp;oldid=prev</id>
		<title>TereseDaye6451: Created page with &quot;Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. [http://Www.Theepoc...&quot;</title>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Stop_Wasting_Time_And_Start_Xarelto_Lawsuit&amp;diff=175268&amp;oldid=prev"/>
				<updated>2018-04-22T16:10:56Z</updated>
		
		<summary type="html">&lt;p&gt;Created page with &amp;quot;Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. [http://Www.Theepoc...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. [http://Www.Theepochtimes.com/n3/search/?q=Pharmaceutical Pharmaceutical] firms, such as the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are working challenging to obtain those hurt by the drug the compensation they may be entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Although bleeding can be a frequent complication connected with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than classic blood thinners due to the fact no antidote exists to reverse its blood-thinning [http://xareltoattorneys.bitbucket.org/categories/Washington/Xarelto-Class-Action-Milton-WA-98354.html side effects to xarelto]. This indicates that, inside the event of an emergency, sufferers may possibly be at threat for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In case you or possibly a loved 1 suffered a serious bleeding event right after taking Xarelto, you may have legal recourse. For a lot more data, get in touch with us today to possess your case reviewed, cost-free of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. Moreover, they are seeking punitive damages, which are typically awarded to punish the defendant and deter other firms from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits Getting Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a secure anticoagulant option.&amp;lt;br&amp;gt;Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.&amp;lt;br&amp;gt;Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for much more information on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;</summary>
		<author><name>TereseDaye6451</name></author>	</entry>

	</feed>